Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial - Concepedia

Concepedia

Publication | Open Access

Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial

DOI Full Paper Access

303

Citations

31

References

2008

Year

Martee L. Hensley, John A. Blessing, Robert S. Mannel, Peter G. Rose

Gynecologic Oncology

Ii TrialMedicineMetronomic TherapyPharmacologyGynecologyFixed-dose Rate GemcitabinePharmacotherapyCancer TreatmentOncologyGynecology OncologyMetastatic Uterine Leiomyosarcoma

References

	Year	Citations

Page 1